Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study
Clinical Pharmacology: Advances and Applications · 2026-05 · Volume 18 · 1-10
DOI: 10.2147/cpaa.s596901 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2026-05. Verfasst von Chen Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Graduate School of WanNan Medical College, Wuhu, People's Republic of China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Graduate School of WanNan Medical College, Wuhu, People's Republic of China.
- Department of Hematology, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei…
- Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, People's Republic of China.
ORCID-Profile: Juan Tong, Changcheng Zheng
Zitieren
APA
Luo, C., Jiang, Y., Yan, H., Sun, K., Li, W., Cao, M., Zhu, L., Hu, X., Tong, J., & Zheng, C. (2026). Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study. Clinical Pharmacology: Advances and Applications, Volume 18, 1-10. https://doi.org/10.2147/cpaa.s596901
Vancouver
Luo C, Jiang Y, Yan H, Sun K, Li W, Cao M, et al. Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study. Clinical Pharmacology: Advances and Applications. 2026;Volume 18:1-10. doi:10.2147/cpaa.s596901
BibTeX
@article{Luo2026,
author = {Luo, Chen and Jiang, Yuhan and Yan, Huiling and Sun, Kan and Li, Wentao and Cao, Mengqing and Zhu, Lijun and Hu, Xing and Tong, Juan and Zheng, Changcheng},
title = {Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2026},
volume = {Volume 18},
pages = {1--10},
doi = {10.2147/cpaa.s596901}
}
EUVIMED